Device Trial Radar · NCT06373666
A Study to Evaluate the Adjustment Function of a Modified Spatz3 Adjustable Balloon (Spatz4).
Last checked: Nov 20, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Aug 9, 2024
Primary completion
Feb 2, 2026
Study completion Feb 2, 2026
Sponsor
- Lead sponsor
- Spatz FGIA, IncAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 18, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the function of the adjustment procedure with the Spatz4 in subjects with a BMI ≥ 27.
Conditions
- Overweight and Obesity
Interventions
Spatz4 Adjustable Balloon SystemDevice
Implantation of Spatz4 Adjustable Balloon system for weight loss treatment for Overweight and Obese patients and Adjustment of the balloon volume at week 16
Primary outcomes
What the sponsor says the trial is designed to measure.
- Successful adjustment procedure at 16 ±2 weeks in > 85% of attempts.Time frame: 16 ± 2 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Endohope Havířov s.r.o.
Havířov, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.